perampanel: Clinical Trials

101 trials of perampanel, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

68 completed, 15 terminated, 8 unknown, 4 recruiting. 31 Phase 2, 20 Phase 1, 18 Phase 3, 14 Phase 4, 3 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 231Completed 21, Terminated 4, Recruiting 2, Unknown 2, Active not recruiting 1, Withdrawn 1
Phase 120Completed 19, Recruiting 1
Phase 318Completed 13, Terminated 5
Phase 414Completed 7, Terminated 5, Unknown 1, Withdrawn 1
Not applicable3Terminated 1, Unknown 1, Withdrawn 1
Early Phase 12Completed 1, Recruiting 1

Follow perampanel: new trials by email Literature Review of perampanel trials Research Report on perampanel

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Senicapoc and Perampanel for Newly Diagnosed Glioblastoma
senicapoc, Perampanel - Glioblastoma
Early Phase 1RecruitingAarhus University Hospital362026-03-012026-05-07
Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus
Perampanel - Refractory Status Epilepticus
Phase 4TerminatedWayne State University12025-10-102025-10-14
PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest
Perampanel, Placebo - Heart Arrest, Seizures
Phase 2RecruitingUniversity of California, San Francisco522024-05-202026-07-29
Bioequivalence Assessment Between Two Perampanel Oral Suspension Formulations
Lepsiramp, 0.5 Mg/mL Oral Suspension, Fycompa, 0.5 Mg/mL Oral Suspension - Bioequivalence Study in Healthy Subjects
Phase 1CompletedAya Mohammed Abdel Magid Abdel Hamid262024-03-072025-08-20
Bioequivalence Study of Perampanel Tablets 10 mg
Perampanel 10 MG, Fycompa 10Mg Tablet - Epilepsy
Phase 1CompletedHumanis Saglık Anonim Sirketi302023-11-222024-06-10
Bioequivalence Study of Perampanel Tablets 12 mg
Perampanel 12 MG, Fycompa 12 mg film-coated tablets - Epilepsy
Phase 1CompletedHumanis Saglık Anonim Sirketi302023-09-142024-06-12
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
Ketamine, Perampanel, Placebo - Depressive Disorder, Major, Post Traumatic Stress Disorder
Phase 1RecruitingYale University502023-09-072026-05-06
The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
Perampanel 6 MG, Ketamine, Placebo - Depressive Disorder, Major Depressive Disorder
Phase 2RecruitingYale University302023-04-032026-05-06
Perampanel in Focal Status Epilepticus
Perampanel, Placebo - Epilepticus; Status, Focal Motor
Phase 3TerminatedAssistance Publique - Hôpitaux de Paris12022-11-022023-12-14
A Study to Evaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Participants With Focal Onset Seizures With or Without Focal to Bilateral Tonic-clonic Seizures
Perampanel - Epilepsy
Phase 4CompletedEisai Korea Inc.1252022-10-192025-03-07
Fycompa in Catamenial Epilepsy
Fycompa, Fycompa with a boost - Catamenial Epilepsy
Phase 4TerminatedUniversity of Florida72022-03-092024-07-31
Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest
Ketamine, Any anti-epileptic and anesthetic therapy, excluding Ketamine and Perampanel - Status Epilepticus, Cardiac Arrest
CompletedUniversity of Milano Bicocca842022-01-152026-07-14
Perampanel Titration and Cognitive Effects
Perampanel 1 week titration, Perampanel 2 week titration, Perampanel 4mg - Epilepsy
Phase 4TerminatedKimford Jay Meador292021-10-202024-06-06
A Multi-center RWS of Perampanel as an add-on Treatment for Epileptic Seizures in Chinese Children
Perampanel - Epilepsy
UnknownBeijing Children's Hospital10002021-07-022022-03-25
Clinical Efficacy and Safety of Perampanel Monotherapy in the Treatment of Children With Focal Epilepsy
perampanel - Focal Epilepsy
UnknownYang Xinwei2802021-07-012022-08-11
Efficacy and Safety of Perampanel in Combination in Glioma-refractory Epilepsy
Perampanel, conventional antiepileptic treatment - Refractory Epilepsy
Not applicableWithdrawnAssistance Publique Hopitaux De Marseille2021-02-152022-06-27
A China RWS to Evaluate the Effectiveness and Safety of Perampanel as an add-on Treatment for Epileptic Seizure
Perampanel - Epilepsy
UnknownBeijing Children's Hospital6002021-01-012022-02-25
Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy
Anticonvulsant Agent, Perampanel, Quality-of-Life Assessment - Intractable Epilepsy, Malignant Glioma
Phase 4TerminatedMayo Clinic42020-12-042023-06-22
Effect of Perampanel on Peritumoral Hyperexcitability in HGG
Perampanel, Standard of Care - Glioma, Malignant, Surgery
Phase 1 / Phase 2CompletedDana-Farber Cancer Institute122020-11-052024-08-05
Open Label Pilot Study of Perampanel for the Treatment of Alcohol Use Disorder
Perampanel Tablet, Disulfiram - Alcohol Disorders
Phase 1 / Phase 2CompletedVirginia Commonwealth University42020-10-152022-10-07

Showing 20 of 101. Sign in to see all of them.

Conditions studied

Epilepsy (37)  ·  Seizures (26)  ·  Parkinson Disease (11)  ·  Epilepsies, Partial (4)  ·  Amyotrophic Lateral Sclerosis (3)  ·  Depressive Disorder, Major (3)  ·  Drug Resistant Epilepsy (3)  ·  Status Epilepticus (3)  ·  Stress Disorders, Post-Traumatic (3)  ·  Bipolar Disorder (2)  ·  Glioma (2)  ·  Heart Arrest (2)  ·  Lennox Gastaut Syndrome (2)  ·  Neuralgia (2)  ·  Alcohol-Related Disorders (1)

Sponsors

Eisai Inc. (37)  ·  Eisai Co., Ltd. (14)  ·  Eisai Limited (7)  ·  Yale University (3)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Beijing Children's Hospital (2)  ·  Eisai Korea Inc. (2)  ·  Humanis Saglık Anonim Sirketi (2)  ·  Mayo Clinic (2)  ·  Virginia Commonwealth University (2)  ·  Aarhus University Hospital (1)  ·  American University of Beirut Medical Center (1)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  Aya Mohammed Abdel Magid Abdel Hamid (1)  ·  Carilion Clinic (1)

Countries

United States (46)  ·  France (14)  ·  Czechia (12)  ·  Germany (12)  ·  Japan (12)  ·  Belgium (11)  ·  South Korea (11)  ·  Spain (11)  ·  Italy (10)  ·  Latvia (9)  ·  India (8)  ·  United Kingdom (8)  ·  Australia (7)  ·  Canada (7)  ·  Hungary (7)

Top investigators

David Squillacote, M.D. (6)  ·  David Squillacote, MD (2)  ·  Fang Fang (2)  ·  John Krystal, MD (2)  ·  Robert Cooper (2)  ·  Aashit Shah, MD (1)  ·  Albert Arias, MD (1)  ·  Albert Arias, MD, PhD (1)  ·  Alessia Nicotra, M.D., Ph.D. (1)  ·  Alessia Nicotra, MD, PhD, DIC (1)  ·  Allison Mann, MD (1)  ·  Antonio Laurenza, M. D. (1)  ·  Antonio Laurenza, M.D. (1)  ·  Bjorn E Oskarsson, MD (1)  ·  Charles A Handforth, M.D. (1)

Results publications

PMID 35305920, PMID 37059702, PMID 25823975, PMID 23663001, PMID 25878175, PMID 21883097, PMID 22517103, PMID 22843280, PMID 22905857, PMID 22913800, PMID 24867391, PMID 26296511, PMID 26724782, PMID 29250772, PMID 29574701, PMID 29653338, PMID 30739576, PMID 31912493, PMID 33681651, PMID 33825230, PMID 33839450, PMID 34657389, PMID 34782307, PMID 34942053, PMID 34953337, PMID 34994582, PMID 35453064, PMID 35596529, PMID 35792849, PMID 36106379, PMID 36746851, PMID 37999939, PMID 39499201, PMID 41249688, PMID 41724127, PMID 42837646

NIH funding

2005 (2), 2014 (2), R21AA026681 (2), 2004 (1), 2017 (1), 2018 (1), 2019 (1), 2025 (1), P50CA165962 (1), R01MH129371 (1)